Article Text

Download PDFPDF
Original research
Psychological symptoms do not discriminate between reflux phenotypes along the organic-functional refractory GERD spectrum
  1. Annelies Geeraerts1,
  2. Livia Guadagnoli2,
  3. Ans Pauwels1,
  4. Hannelore Geysen1,
  5. Thomas Neyens3,4,
  6. Lukas Van Oudenhove2,5,
  7. Tim Vanuytsel1,6,
  8. Jan Tack1,6
  1. 1 Translational Research Center for Gastrointestinal Disorders (TARGID), Department of Chronic Diseases and Metabolism (CHROMETA), KU Leuven, Leuven, Belgium
  2. 2 Laboratory for Brain-Gut Axis Studies (LaBGAS), Translational Research Center for Gastrointestinal Disorders (TARGID), Department of Chronic Diseases and Metabolism (CHROMETA), KU Leuven, Leuven, Belgium
  3. 3 Leuven Biostatistics and Statistical Bioinformatics Centre, Department of Public Health & Primary Care, KU Leuven, Leuven, Belgium
  4. 4 Interuniversity Institute for Biostatistics and Statistical Bioinformatics, Data Science Institute, Hasselt University, Hasselt, Belgium
  5. 5 Leuven Brain Institute, KU Leuven, Leuven, Belgium
  6. 6 Department of Gastroenterology, UZ Leuven, Leuven, Belgium
  1. Correspondence to Dr Livia Guadagnoli, Laboratory for Brain-Gut Axis Studies (LaBGAS), Translational Research Center for Gastrointestinal Disorders (TARGID), Department of Chronic Diseases and Metabolism (CHROMETA), KU Leuven, Leuven, Flanders, Belgium; Livia.guadagnoli{at}kuleuven.be

Abstract

Objective Historically, psychological processes are associated with disorders at the functional end of the gastro-oesophageal reflux disease (GERD) spectrum. However, recent research suggests that psychological symptoms are relevant across the entire GERD spectrum. We aim to investigate whether psychological symptoms are associated with reflux phenotype (True GERD, Borderline GERD, reflux hypersensitivity, functional heartburn) along the GERD spectrum in a cohort of refractory reflux patients.

Design Consecutive adult patients with refractory reflux symptoms underwent standard 24-hour pH-impedance monitoring and completed questionnaires assessing demographic, clinical and psychological information. Bayesian one-way analysis of variance assessed whether psychological variables differed across reflux phenotypes. Next, we applied multinomial and ordinal logistic regressions with clinical, demographic and psychological variables set as independent variables and reflux phenotype as the outcome variable. The complementary machine-learning approach entered all demographic, clinical and psychological variables into models, with reflux phenotype set nominally and ordinally. Cross-validated model performance was used to select the best model.

Results 393 participants (mean (SD) age=48.5 (14.1); 60% female) were included. The Bayesian analyses found no difference in psychological variables across reflux phenotypes. Similarly, age, gender and proton pump inhibitor use were the only significant variables in the multinomial logistic regression and body mass index was significant in both regressions. Machine-learning analyses revealed poorly performing models with high misclassification rates (67–68%) in both models.

Conclusion Psychological symptoms do not differ between nor predict reflux phenotype membership in refractory reflux patients. Findings suggest that psychological symptoms are relevant across the spectrum of GERD, rather than specific to functional oesophageal disorders.

  • GASTROESOPHAGEAL REFLUX DISEASE
  • PSYCHOLOGY
  • OESOPHAGEAL REFLUX

Data availability statement

No data are available.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Data availability statement

No data are available.

View Full Text

Footnotes

  • AG and LG are joint first authors.

  • LVO, TV and JT are joint senior authors.

  • Twitter @GuadagnoliLivia

  • Contributors AG and LG contributed equally to this paper and are joint first authors. LVO, TV and JT are joint senior authors. LG, AG and LVO contributed to study concept and design, analysis and interpretation of data, and drafting of the manuscript; HG and AP contributed to data acquisition and critical revision of the manuscript; TN contributed to statistical analysis and critical revision of the manuscript; TV and JT contributed to study concept and design and critical revision of the manuscript. LG is guarantor of the manuscript.

  • Funding LG is a postdoctoral research fellow of the Research Foundation Flanders (FWO, 12A7822N). TV is a senior clinical research fellow of the Research Foundation Flanders (FWO, 1830517N). LVO is a research professor of the KU Leuven Special Research Fund.

  • Competing interests None declared.

  • Patient and public involvement Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.